Abbott Laboratories (ABT) vs DexCom, Inc. (DXCM)
- Abbott Laboratories ABT 104.88 +0.19%
- DexCom, Inc. DXCM 86.06 −1.88%
Abbott Laboratories and DexCom, Inc. are both Medical Devices companies. Abbott Laboratories is the larger, with a market value of $181.1B against $33.1B — 5.5× the size. DexCom, Inc. trades at the lower P/E: 33.2× against 33.9×. DexCom, Inc. grew revenue faster over the last twelve months: 15.5% against 8.06%. DexCom, Inc. has the higher net margin (20.1% vs 11.7%) and the higher return on invested capital (37.1% vs 5.83%). Across the 22 metrics below, DexCom, Inc. leads on 16 and Abbott Laboratories on 6.
Valuation
Profitability
| Metric | ABT | DXCM | Medical Devices median |
|---|---|---|---|
| Gross margin | 56.61% | 62.47% | 56.01% |
| Operating margin | 15.77% | 22.92% | (15.03%) |
| Net margin | 11.65% | 20.12% | (20.40%) |
| Free cash flow margin | 16.80% | 28.27% | (7.24%) |
| Return on equity | 10.58% | 38.49% | (15.32%) |
| Return on assets | 5.62% | 14.51% | (19.72%) |
| Return on invested capital | 5.83% | 37.13% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack